{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:56:07Z","timestamp":1787637367699,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bmcl.2020.127207","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T11:38:02Z","timestamp":1587469082000},"page":"127207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT"],"prefix":"10.1016","volume":"30","author":[{"given":"Alina","family":"Ciammaichella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ferrigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreina","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Biancofiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ponzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vittoria Orsale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Fini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Paonessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Ontoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127207_h0005","unstructured":"World Health Organization (WHO), Trypanosomiasis, human African (sleeping sickness); http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/; Accessed 17 April 2019."},{"key":"10.1016\/j.bmcl.2020.127207_h0010","doi-asserted-by":"crossref","first-page":"e1896","DOI":"10.1371\/journal.pntd.0001896","volume":"6","author":"Sykes","year":"2012","journal-title":"PLoS Negl."},{"key":"10.1016\/j.bmcl.2020.127207_h0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.trstmh.2005.03.017","volume":"100","author":"P\u00e9pin","year":"2006","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"6","key":"10.1016\/j.bmcl.2020.127207_h0020","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1371\/journal.pntd.0001695","volume":"2012","author":"Kuepfer","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmcl.2020.127207_h0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","volume":"45","author":"Priotto","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bmcl.2020.127207_h0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2020.127207_h0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","volume":"56","author":"Alirol","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bmcl.2020.127207_b0020","doi-asserted-by":"crossref","unstructured":"(a) Torreele E, Trunz BB, Tweats D, Kaiser M, Brun R, Mazue G, Bray MA, Pecoul B, PLoS Negl Trop Dis. 2010;4:e923; b) DNDi (Drugs for Neglected Diseases initiative); https:\/\/www.dndi.org\/diseases-projects\/portfolio\/fexinidazole\/; Accessed 23 March 2020.","DOI":"10.1371\/journal.pntd.0000923"},{"key":"10.1016\/j.bmcl.2020.127207_b0025","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.bmcl.2018.10.028","volume":"28","author":"Ferrigno","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2020.127207_h0050","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/jm9004303","volume":"52","author":"Kinzel","year":"2009","journal-title":"J. Med. Chem."},{"issue":"39","key":"10.1016\/j.bmcl.2020.127207_h0055","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1080\/00498250903082279","volume":"2009","author":"Fonsi","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bmcl.2020.127207_b0035","unstructured":"Calculated properties were generated using ChemAxon soft-ware version 15."},{"key":"10.1016\/j.bmcl.2020.127207_b0040","unstructured":"Biancofiore I, Ciammaichella A, Ferrigno F, Harper S, Malancona, S, Ontoria J M, Paonessa G, Ponzi S, Summa V, WO 2018\/115275 A1."},{"key":"10.1016\/j.bmcl.2020.127207_b0045","first-page":"1","volume":"10","author":"Thomsen","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20303073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20303073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:33:42Z","timestamp":1760772822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20303073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0960894X20303073"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127207","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127207"}}